215 related articles for article (PubMed ID: 15648187)
1. How should we move the field of chemopreventive agent development forward in a productive manner?
Meyskens FL; Szabo E
Recent Results Cancer Res; 2005; 166():113-24. PubMed ID: 15648187
[TBL] [Abstract][Full Text] [Related]
2. The role of chemoprevention in cancer control.
Greenwald P; Kelloff GJ
IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
4. Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.
Kelly RJ; Lopez-Chavez A; Szabo E
Curr Drug Targets; 2011 Dec; 12(13):1983-8. PubMed ID: 21158704
[TBL] [Abstract][Full Text] [Related]
5. Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA
J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195
[TBL] [Abstract][Full Text] [Related]
6. Cancer chemoprevention. A new way to treat cancer before it happens.
Krishnan K; Ruffin MT; Brenner DE
Prim Care; 1998 Jun; 25(2):361-79. PubMed ID: 9628956
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention.
Greenwald P; Kelloff G; Burch-Whitman C; Kramer BS
CA Cancer J Clin; 1995; 45(1):31-49. PubMed ID: 7804897
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of human cancer: a reasonable strategy?
Meyskens FL
Recent Results Cancer Res; 1999; 151():113-21. PubMed ID: 10337722
[TBL] [Abstract][Full Text] [Related]
9. New opportunities in chemoprevention research.
Kucuk O
Cancer Invest; 2002; 20(2):237-45. PubMed ID: 11901544
[TBL] [Abstract][Full Text] [Related]
10. Curcumin chemoprevention: the long road to clinical translation.
Shureiqi I; Baron JA
Cancer Prev Res (Phila); 2011 Mar; 4(3):296-8. PubMed ID: 21372027
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemoprevention: progress and promise.
Kelloff GJ; Sigman CC; Greenwald P
Eur J Cancer; 1999 Dec; 35(13):1755-62. PubMed ID: 10673988
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of human trial findings.
Huttunen JK
IARC Sci Publ; 1996; (139):271-6. PubMed ID: 8923037
[TBL] [Abstract][Full Text] [Related]
13. Cancer chemoprevention: a rapidly evolving field.
Steward WP; Brown K
Br J Cancer; 2013 Jul; 109(1):1-7. PubMed ID: 23736035
[TBL] [Abstract][Full Text] [Related]
14. Multiagent chemopreventive agent combinations.
Brenner DE
J Cell Biochem Suppl; 2000; 34():121-4. PubMed ID: 10762024
[TBL] [Abstract][Full Text] [Related]
15. The retinoids and cancer prevention mechanisms.
Dragnev KH; Rigas JR; Dmitrovsky E
Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
[TBL] [Abstract][Full Text] [Related]
16. Intermediate biomarkers of precancer and their application in chemoprevention.
Kelloff GJ; Malone WF; Boone CW; Steele VE; Doody LA
J Cell Biochem Suppl; 1992; 16G():15-21. PubMed ID: 1469895
[TBL] [Abstract][Full Text] [Related]
17. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
Sanner T; Dybing E
Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of human trial design.
Buiatti E
IARC Sci Publ; 1996; (139):261-9. PubMed ID: 8923036
[TBL] [Abstract][Full Text] [Related]
19. Strategies for intervention with chemopreventive agents.
Lipkin M
Int J Cancer; 1996 Feb; 69(1):64-7. PubMed ID: 8600066
[TBL] [Abstract][Full Text] [Related]
20. Strategy and planning for chemopreventive drug development: clinical development plans II.
Kelloff GJ; Crowell JA; Hawk ET; Steele VE; Lubet RA; Boone CW; Covey JM; Doody LA; Omenn GS; Greenwald P; Hong WK; Parkinson DR; Bagheri D; Baxter GT; Blunden M; Doeltz MK; Eisenhauer KM; Johnson K; Knapp GG; Longfellow DG; Malone WF; Nayfield SG; Seifried HE; Swall LM; Sigman CC
J Cell Biochem Suppl; 1996; 26():54-71. PubMed ID: 9154168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
